NetworkNewsBreaks – Lexaria Bioscience Corp.’s
Post# of 721
(Total Views: 221)
Posted On: 06/13/2019 5:45:23 PM
NetworkNewsBreaks – Lexaria Bioscience Corp.’s (CSE: LXX) (OTCQX: LXRP) Technology Credited as Major Factor in 1906 Edibles Appeal
Biotechnology company and drug delivery platform innovator Lexaria Bioscience’s (CSE: LXX) (OTCQX: LXRP) DehydraTECH(TM) is credited as part of the major appeal of Nuka Enterprises LLC’s 1906 cannabis edibles. A recent article quotes Nuka CEO and co-founder Peter Barsoom, where he states, “As the fastest-growing edibles brand in Colorado, we believe a huge part of our consumer appeal is because of this fast-acting technology. We look forward to continuing to innovate alongside Lexaria, whose technology is the best in the industry.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
Biotechnology company and drug delivery platform innovator Lexaria Bioscience’s (CSE: LXX) (OTCQX: LXRP) DehydraTECH(TM) is credited as part of the major appeal of Nuka Enterprises LLC’s 1906 cannabis edibles. A recent article quotes Nuka CEO and co-founder Peter Barsoom, where he states, “As the fastest-growing edibles brand in Colorado, we believe a huge part of our consumer appeal is because of this fast-acting technology. We look forward to continuing to innovate alongside Lexaria, whose technology is the best in the industry.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)Lexaria Bioscience Corp. (LXRPD) Stock Research Links
Scroll down for more posts ▼